GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Trinity Biotech PLC (NAS:TRIB) » Definitions » Price-to-Free-Cash-Flow
中文

Trinity Biotech (Trinity Biotech) Price-to-Free-Cash-Flow : N/A (As of Apr. 25, 2024)


View and export this data going back to 1995. Start your Free Trial

What is Trinity Biotech Price-to-Free-Cash-Flow?

As of today (2024-04-25), Trinity Biotech's share price is $1.83. Trinity Biotech's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2023 was $-1.69. Hence, Trinity Biotech's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for Trinity Biotech's Price-to-Free-Cash-Flow or its related term are showing as below:

During the past 13 years, Trinity Biotech's highest Price-to-Free-Cash-Flow Ratio was 268.87. The lowest was 2.32. And the median was 4.07.

TRIB's Price-to-Free-Cash-Flow is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 27.41
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

Trinity Biotech's Free Cash Flow per Share for the three months ended in Sep. 2023 was $-0.69. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $-1.69.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was 6.80% per year.

During the past 13 years, Trinity Biotech's highest 3-Year average Free Cash Flow per Share Growth Rate was 318.80% per year. The lowest was -75.40% per year. And the median was 9.10% per year.


Trinity Biotech Price-to-Free-Cash-Flow Historical Data

The historical data trend for Trinity Biotech's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Trinity Biotech Price-to-Free-Cash-Flow Chart

Trinity Biotech Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 5.87 6.57 -

Trinity Biotech Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Trinity Biotech's Price-to-Free-Cash-Flow

For the Diagnostics & Research subindustry, Trinity Biotech's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Trinity Biotech's Price-to-Free-Cash-Flow Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Trinity Biotech's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Trinity Biotech's Price-to-Free-Cash-Flow falls into.



Trinity Biotech Price-to-Free-Cash-Flow Calculation

Trinity Biotech's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=1.83/-1.688
=N/A

Trinity Biotech's Share Price of today is $1.83.
Trinity Biotech's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.69.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Trinity Biotech  (NAS:TRIB) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Trinity Biotech Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Trinity Biotech's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Trinity Biotech (Trinity Biotech) Business Description

Traded in Other Exchanges
Address
IDA Business Park, Bray, County Wicklow, Dublin, IRL, A98 H5C8
Trinity Biotech PLC is in the business of development, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point of care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Premier, Immublot, EZ, Capita, and others. Geographically, it has two segments namely the Americas, and Rest of World - Ireland of which it derives a majority of its revenues from the Americas segment.